Business Standard
Thursday, Feb 16, 2012
Sponsored by  
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
|||||Opinion|||| 
 Section Home | Editorials | Compass | BS People | Columnists | Lunch with BS
Home > Opinion & Analysis Live Markets | Commodities
 

Don't sue the science guys
Nilanjana S Roy / New Delhi Aug 11, 2009, 00:56 IST

Simon Singh authored the first book about mathematics to become a number one bestseller in the UK, Fermat’s Last Theorem. His next two books, The Code Book and The Big Bang, are among the most lucid and precise examples of science writing you might read today. He’s a great entertainer, electrocuting gherkins on stage as an example of the “red shift” effect that helps prove the universe is expanding.

He’s also at the centre of a growing debate about science writing, libel laws and the rise of pseudoscience. About a year ago, Simon Singh wrote “Beware the spinal trap”, an article that examined the claims made by chiropractors. In the piece, Singh evaluated the risks involved in undergoing chiropractic treatment, and dismissed some claims—that chiropractors can treat children with asthma, colic and other ailments—as “utter nonsense” and “bogus”. This seemed to be a routine, if well-researched piece; Singh offered evidence of the links between bad chiropractic techniques and heart strokes, and seemed to back up his scepticism with facts.

The British Chiropractic Association sued Singh, claiming that he had defamed their reputation, and as of August 4, the writer was fighting for the right of permission to appeal in what has become a key libel case. Libel suits are feared in the UK—they are expensive, with costs for the defence usually running well over £100,000, and the burden of proof rests with the defence. Though much of the case concerns Singh’s use of the word “bogus”—to the delight of language scholars who’ve been blogging learned definitions and word origins—the broader issue is whether libel laws should apply to science writing.

The reason why Simon Singh is willing to go through the long, grim and financially draining process of a court case rather than issue a general apology is because he believes that science writers should be free to question dodgy science or pseudo-scientific claims. Libel suits are an easy way to prevent science writers from tackling certain subjects—as the pharmacological industry well knows. Over time, the threat of libel acts as a deterrent, preventing public inquiry into subjects that affect us at a very basic level. The pressure group Sense About Science has been running a very successful Keep Libel Laws Out of Science campaign, and is now in touch with PEN and other free-speech groups.

As an illustration of how important it is to promote freedom of speech in science writing, consider the case of Dr Ben Goldacre. His book, Bad Science, is on the Aventis Science Writing shortlist for 2009, and includes Goldacre’s debunking of vitamin pill magnate Matthias Rath’s dangerous claims in a campaign in Africa that anti-Aids drugs were poisonous, and that his vitamins were the true cure. Goldacre writes, “This chapter did not appear in the original edition of this book, because for fifteen months leading up to September 2008 the vitamin-pill entrepreneur Matthias Rath was suing me personally, and the Guardian, for libel. The Guardian generously paid for the lawyers, and in September 2008 Rath dropped his case, which had cost in excess of £500,000 to defend. Rath has paid £220,000 already, and the rest will hopefully follow. Nobody will ever repay me for the endless meetings, the time off work, or the days spent poring over tables filled with endlessly cross-referenced court documents.”

There’s a chilling lesson to be drawn here. Had Goldacre been more easily intimidated, or had the Guardian been less willing or able to fight such an expensive court case, the truth about Rath’s claims may never have come to public attention. Much of science writing today is pressed into the service of debunking pseudoscience—as with the patient and necessary attacks on creationist “theories” of evolution, or with examining the claims made by the pharma, food and alternative therapy industries. Many scientists are employed by these industries, and it’s for the independent researcher/writer to offer the other side, or to examine claims more carefully.

It would have been so easy for Simon Singh to offer a ritual apology, and to save himself the trouble he’s been put to over the last twelve months. But he believes that his article addressed an important area of public awareness, especially with regard to children’s health—and he believes he did not defame chiropractors by drawing attention to the risks of the practice itself. “As a journalist,” he writes in a recent statement, “I have always been aware of the libel laws, but I don’t think I ever fully appreciated the chilling effect they have on journalism — important articles are withdrawn and other stories are simply not commissioned because of the fear of libel.” It’s this absence, this rarely discussed silence, that Simon Singh and others like him are defending, in the UK and elsewhere.

nilanjanasroy@gmail.com  

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- S&P reaches 7-month high before hitting wall
- World Bank President Zoellick to step down on June 30
- Oil cos cut jet fuel prices by Rs 350/kl
- Telcos operating profit to rise 5% in 2 yrs: Crisil
- PESB recommends SS Narsing Rao for CIL's top slot
  Read Business news in 
- Now property search gets more exciting than ever before!
- IndianOil Citibank Card at Zero annual card fee
- We live for our family. have you secured them?
- Earn fuel worth Rs.2400 with Citi
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Win a Business Class Ticket to Europe..Know more..
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Medium-sized businesses are the engines of a smarter planet.
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Office 365 for professionals and small businesses.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Kanika Datta: The importance of being SRK
- Leela parts ways with Kempinski
- Tata Motors soars to record level as JLR propels profit
- Tailor-made but not good enough
- Nestle: Food for thought
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only
  Buy Now
  Now available on the Kindle Store...
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
  Hot Searches  
 
IRFC bond |  Antrix-Devas |  Rafale fighter |  Junglee |  IPL 5 |  Dhanlaxmi Bank |  Thomas Cook |  TCS |  Sarfaesi Act |  Vodafone |  Aakash tablet |  Sodexo |  Rupee |  Samsung Galaxy Note |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  Anna Hazare |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us